Movement Alert|Progressive Rises 3.07% in Regular Trading, Morgan Stanley Upgrades Rating to Equal-Weight

Market Focus
Jul 24

On July 24, Progressive rose 3.07% in regular trading, trading at $213.255/share, with turnover of $115 million. The rally was driven by Morgan Stanley upgrading the stock from underweight to equal-weight and raising its price target from $190 to $210.

Morgan Stanley noted that Progressive's recent share price decline represents a reset on valuation and thesis. Although the insurance industry is experiencing challenging growth with some firms seeing auto premiums decline, Progressive's premium growth, while slowing, remains notably better than the rest of the sector. The analysts highlighted the company's flexibility between bundled and mono-line auto businesses as a structural advantage, noting that some carriers have over-emphasized home and auto bundling, which can restrict growth. This upgrade marks the first positive signal following a series of recent downgrades after Q2 results, during which multiple institutions slashed price targets. Progressive reported Q2 EPS of $5.67, beating the FactSet consensus of $5.35, though net income declined in June, triggering prior selling pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10